EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19

Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.

PmkyMGRtw6F0dCQgcVXDrXVtw6kge8OJRDBkacOtMGnhu5tvMDgxMHVzw63hu4PDujDDmlTEkDBuw7rDoTB1acO64buTZDBzw6luxJHDqXTDrXfDrXMwZcOt4buHw7owdXPhu4kwRMOTV8ONxJAtMmE+L2kyez5xMGRtw6F0dCQgcUnDqcOhxJEge09p4bq3bjBlw6BxMOG7q29oMG9pw7owZOG6rcO6MGThuqdxMGPDoGRpMGnDreG7g28wb8Ohw70wZGnDszBkw6BkMGPhu4NvaTBvaeG6pW8wbuG6sWQwxJHhu4lkaTB3w63hur9uMGXhu6nhu6NvaDBp4buRMGnhuqdxMGThuqdxMETDk1fDjcSQLTJhMOG7oTBkaeG6pcO6MOG6pMO6LjBvaOG6ocO9MDNhLzguMMWow70wY8OhbzBkaeG6pcO6MOG6pMO6MCnDiUQ8MHVp4buRb2gwY8Ogw7MwZcSDMGXhu5lvaDDhu7MwbsO6w6EwdWnDuuG7k2QwbGnDoG9oMHfDrXPDunQwc8OpbsSRw6l0w613w61zMHfhu5NvMGxpw6FvMGnDreG7gW4wZMWpw6EwZOG7kW9oMHXDvTDEkeG7qeG7n2QwcWnhuqtuME5BMEjDrW3DqcOhxJEwVGTDrcOpb2TDqXQhPi9xez5xMGRtw6F0dCQgcUPDs8SRw70gez7DrW5oMGRtw6F0dCQgZG50LXFpw7N1w7MgMHXDrXVtw6kkIMOJRDBkacOtMGnhu5tvMDgxMHVzw63hu4PDujDDmlTEkDBuw7rDoTB1acO64buTZDBzw6luxJHDqXTDrXfDrXMwZcOt4buHw7owdXPhu4kwRMOTV8ONxJAtMmEwaeG7i29pMMOjb2kwMiAwdHNkJCAvL2QhY8Ohw7N1acOhb2lpw7PDoSF3by/DrW5oL8SRw6l0bHXDs3Evb8OpeHQvMzE0MS8yODjEkTUxOTVhMjV1Mzg2OG0yIXjDqWNxIDDDoW11JCDDiUQwZGnDrTBp4bubbzA4MTB1c8Ot4buDw7oww5pUxJAwbsO6w6EwdWnDuuG7k2Qwc8OpbsSRw6l0w613w61zMGXDreG7h8O6MHVz4buJMETDk1fDjcSQLTJhIDDEkcOhdcOhLXFpw7N1w7Mtw7Nzw61ow61vw6FtLXRzZCQgaXV1cXQ7Ly9kxJFvw61uaCF3w63DqXVvw6FucW3DunQhd28vdTczMS/DunFtw7PDocSRw6nEkS9xZGfDsy8zMTMxXzE4XzNhL3V1eXdvXzNhMThfc8OpbsSRw6l0w613w61zIWtxaCAwL3tVacO64buTZDBTw6luxJHDqXTDrXfDrXMwZeG7qeG7n2QwaMOt4budw60wdWnDreG7g8O6MHXhuqPDrTBJw6FuY8O6c2guMEXhu6tkITApw4NvaTsww4FHUS9VVVlXTzw+L3F7PnEwZG3DoXR0JCBxQ8OzxJHDvSB7VXPDs29oMHXDusO94bq/bzBj4buTMGTFqcOhMG7hu4tvaS4ww4lEMGRpw7MwY8Ot4buBdTBlxIMwZGnhuqdxMHVpw7rhuqlvMGRpw60wNzQwdXPDreG7g8O6MMOpw7pzw7MwKTg1MHVzw63hu4PDujDDmlTEkDwwZeG7hTBuw7rDoTB1acO64buTZDBzw6luxJHDqXTDrXfDrXMwd+G7ncOtMHThu5MwbcOt4buHw7owZcWpMGXhu4UwZcOt4buHw7owdXPhu4kwZGnDszBsacOzw6NvaDA0MSExMTEwY+G7g29pMG9p4bqlbyE+L3F7PnEwZG3DoXR0JCBxQ8OzxJHDvSB7VWnDqcOzMGThu5swcsO6w6FvMGXDreG7h8O6MGnhuqFvaTBkxanDoTBNw63hur9vMG7DrW9pMGRp4bqlw7ow4bqkw7owKcOJw5o8LjB1acO1w6EwdWnDuuG6qW8wb+G6ocO9MHTDqjBkacSpMGjDrcOjw60wcsO6w73hu4F1MG9pdm9oMG9pw7owZOG6rcO6MHVz4bup4budZDBu4bqxdTB34bqhMMOJRDBlw6FvaDB5w7lkMHXDreG7gW8wZeG7hTBlw6NuMGPDo8OzMGTDsjB1aeG7hTBuw7rDoTBkw6BkMG3DreG7h8O6MHVpw7rhu5NkMG7hu53DrTB14buxMHVpw6BvaDAyMTB14budw60hPi9xez5xMGRtw6F0dCQgcUPDs8SRw70ge1PDqW7EkcOpdMOtd8OtczBt4bqhMHTDo28wcWnhuqtuMGTFqcOhMGThu5FvaDB1w70wTkEwSMOtbcOpw6HEkTBUZMOtw6lvZMOpdDB34bqhMG3huqEwbcOz4bqjw60wdWnDuuG7k2QwZeG6rcO6MHXDreG6v28wZGnDszBs4buBdTByw7rDozBsacOjMHLDusOhbzB1c8Ozb2gwd8Ot4buDZDBlw63hu4fDujB1c+G7iTBj4buDb2kwb2nhuqVvMG7hurFkMETDk1fDjcSQLTJhMHVzw7NvaDBkw6BkMHVp4buvMG9oacOt4buDbjBt4bqlbjB04bqhb2gwZGnDrG9pMHVp4burZCE+L3F7PnEwZG3DoXR0JCBxQ8OzxJHDvSB7RGnDszB14budw60wb8Ohw70uMGXhuqXDvTBkxrBvaDBt4bqhMG3Ds+G6o8OtMHVpw7rhu5NkMMSRw7rDvTBvaeG6p3UwZeG7qeG7n2Qww4lEMGThuqdxMHFp4bq5cTB04buvMMSR4bunb2gwZeG7hTBlw63hu4fDujB1c+G7iTBj4buDb2kwb2nhuqVvMG7hurFkMETDk1fDjcSQLTJhITBVw7rDvTBvacOt4bq/by4wcWnhuq1vMG3hu51vMG9ow7rhu5lvMGTDum9oMHVpw7rhu5NkMHPDqW7EkcOpdMOtd8OtczBl4buHw7owZcSDMGPhu4kwTkEwdWnDujBuw7rDoSE+L3F7PnEwZG3DoXR0JCBxQ8OzxJHDvSB7VWnDoG9oMDcwd+G7scOhMHLDusOhLjBOQTBlxIMwbOG7szBp4bufcTBl4buZb2gwd+G7ncOtMEjDrW3DqcOhxJEwVGTDrcOpb2TDqXQwZeG7hTBl4bqzdTBp4bqhb2gwaeG7m28wNjExITExMTBtw63hu4fDujBzw6luxJHDqXTDrXfDrXMuMGRpw63hu4FuMHFp4bqtbzBt4budbzBt4bup4bufb2gwdMOjbzB5w7rhuqd1MGTFqcOhMGThu5FvaDB1w70wxJHhu6nhu59kMHFp4bqrbjBv4bqhw70wdXPDs29oMGnhu4F1MHVpw6BvaDBhIT4vcXs+cTBkbcOhdHQkIHFDw7PEkcO9IHtO4bqzZDDEkeG7pTBp4bqtw7owaeG7gXUwZMOgZDBv4bup4budZDBkaeG6pcO6MOG6pMO6MGXEgzByw7rDoTBlxKlvaTDEkeG7iWRpMETDk1fDjcSQLTJhLjB1w7rDvTBvacOt4bq/by4wbuG7lXUw4oCcbeG6oW8wdMOyb2gwxJHhu4lkaTBj4buDb2kwdWnhu6swacOhw63igJ0wZcOhb2gwaeG7i29pMHVp4bqhb2kwdXPDs29oMG9pdm9oMG9o4bqhw70waOG6rW8wZeG6pcO9MGXEgzBsacOt4buBbzBvacOt4buHw7owcsO64buTZDBow63DoTB1w6DDrTDDoHEwZeG6s3UwZMOgZDBjw63hu4NvMHFpw6BxMGnhuqNvMGRp4buBMG9p4bq3bjBvaOG6r28wZGnhurNvMMSR4buJZGkwY+G7g29pMG3huqXDvTBtw6FvIT4vcXs+cTBkbcOhdHQkIHFDw7PEkcO9IHtU4buTMGPhu4NvaTBvaeG6pW8wb2nhuqlxMHfDreG7g28wdeG6o8OtMGRp4bqlw7ow4bqkw7owZcOhb2gwb2jhuqHDvTBu4buVdTBow63DoTB14bqvb2guMHTDs29oMHdibzBk4buNbzB1aeG6p3EwaeG7m28wb2nDreG7h8O6MHTDszB34budw60wZeG7n3UwY+G7pW9oMHFpw6B1MGnhu5nDrTB1acOgb2gwNC01LjB1aeG7o8OtMGXDreG7hW4wbuG7lXUwbcOz4bqjdTBj4buDb2kwd8Ot4buDbzB14bqjw60wb2nDreG7h8O6MG/hu6nhu51kMHVz4buhMG/hur9vMHLDusOgMHXDo8OtIS8hPi9xez5xMGRtw6F0dCQgccOBw7p1acOzcyB7KVVVWVdPL1fDrcOpdW/DoW4rPD4vcXs=

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Nhà lãnh đạo Triều Tiên thị sát, chỉ đạo diễn tập “chuẩn bị tác chiến”

Nhà lãnh đạo Triều Tiên thị sát, chỉ đạo diễn tập “chuẩn bị tác chiến”

Thế giới
(Baothanhhoa.vn) - Nhà lãnh đạo Triều Tiên Kim Jong Un vừa trực tiếp thị sát các cuộc diễn tập kết hợp giữa bộ binh và xe tăng, đồng thời kiểm tra mẫu xe tăng chiến đấu chủ lực thế hệ mới, trong khuôn khổ các hoạt động được mô tả là nhằm tăng cường năng lực sẵn sàng quân sự.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh